Zinc is required as a catalytic, structural (zinc fingers) and regulatory i
on. In this capacity, it is involved in many homeostatic mechanisms, includ
ing immune responses. Metallothioneins (MTs) may play key roles because of
their preferential binding to zinc especially in ageing. MTs protect from o
xidative damage during transient stress conditions at young-adult age. This
protection no longer exists in ageing and in age-related diseases (cancer
and infections) because the stress condition is constant. As such, MTs may
constantly deplete zinc from plasma and tissues. This phenomenon causes inc
reased MTs levels on the one hand, but on the other hand induces low zinc i
on bioavailability for normal immune responses. This may be particularly re
levant for thymic functions and natural killer activity. Therefore MTs whic
h are protective in young-adults may become dangerous in immune responses d
uring ageing. Physiological supplementation of zinc in ageing corrects cent
ral and peripheral immune defects, resulting prolonged survival and decreas
ed mortality (50%) from infections and tumours, especially during middle ag
e. Because of increased MT gene expression and protein levels in the liver
and atrophic thymus of old mice, MTs are proposed as genetic markers of imm
unosenescence.